Sophia Genetics SANASDAQ:SOPH
- LAST PRICE5.0600
- TODAY'S CHANGE (%)0.0500 (0.9980%)
- Bid / Lots4.0200/ 1
- Ask / Lots5.7500/ 2
- Open / Previous Close4.9900 / 5.0100
- Day Range
- 52 Week Range
- Volume32,198
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SOPH |
|---|---|---|
| 09:32 ET | 1102 | 4.99 |
| 09:43 ET | 894 | 4.8503 |
| 10:19 ET | 100 | 4.93 |
| 10:51 ET | 8916 | 4.95 |
| 11:06 ET | 100 | 5 |
| 11:26 ET | 4547 | 4.9 |
| 11:29 ET | 100 | 4.9225 |
| 11:33 ET | 1525 | 4.95 |
| 11:36 ET | 100 | 4.95 |
| 11:40 ET | 100 | 4.95 |
| 11:45 ET | 225 | 4.95 |
| 12:32 ET | 100 | 4.97 |
| 01:37 ET | 1000 | 4.9923 |
| 01:51 ET | 680 | 5 |
| 02:11 ET | 2010 | 5 |
| 02:36 ET | 150 | 5.04 |
| 02:40 ET | 600 | 5.04 |
| 02:42 ET | 150 | 5.0363 |
| 02:45 ET | 209 | 5.07 |
| 03:02 ET | 200 | 5.04 |
| 03:14 ET | 119 | 5.02 |
| 03:32 ET | 500 | 5.0338 |
| 03:45 ET | 1306 | 4.96 |
| 03:59 ET | 500 | 5.06 |
Today
Apr 17, 2024
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD), from 6:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
6:05AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 4, 2024
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership, from 1:00AM ET on Thursday Apr 04, 2024 by Dow Jones
1:00AM ET on Thursday Apr 04, 2024 by Dow Jones
Apr 2, 2024
Laboratorio Barnafi-Krause is Live on SOPHiA DDM(TM), from 10:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
10:00AM ET on Tuesday Apr 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sophia Genetics SA | 327.2M | -4.1x | --- |
Red Violet Inc | 243.4M | 18.0x | --- |
Arteris Inc | 246.0M | -6.3x | --- |
Perfect Corp | 230.2M | 50.8x | --- |
Exodus Movement Inc | 208.3M | -12.1x | --- |
Snail Inc | 39.0M | -4.3x | --- |
Company Information
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.
Contact Information
- Headquarters
- La Piece 12ROLLE, Switzerland 1180
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Troy Cox
- Chief Executive Officer, Co-Founder, Director
- Jurgi Camblong
- Chief Financial Officer
- Ross Muken
- Chief People Officer
- Manuela Da Silva Valente
- Chief Scientific Officer
- Zhenyu Xu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $327.2M |
|---|---|
Revenue (TTM) | $62.4M |
Shares Outstanding | 65.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.22 |
Book Value | $2.32 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 5.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -119.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
